SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
ERIS Lifesciences Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540596 INE406M01024 184.651184 ERIS 0.41 24,382.73 315.18 5.68 1
Quarters :
ParticularsMar 2025(Rs.Cr)Dec 2024(Rs.Cr)Sep 2024(Rs.Cr)
Gross Sales395.71390.00428.75
Other Operating Income9.069.737.81
Other Income 16.757.795.81
Total Income421.52407.52442.37
Total Expenditure 283.80300.16293.93
PBIDT137.72107.36148.44
Interest 53.1654.6556.26
PBDT84.5652.7192.18
Depreciation43.3846.6846.16
Tax8.510.008.78
Fringe Benefit Tax0.000.000.00
Deferred Tax2.204.259.14
Reported Profit After Tax30.471.7828.10
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item30.471.7828.10
    
EPS (Unit Curr.)2.240.132.06
EPS (Adj) (Unit Curr.)2.240.132.06
Calculated EPS (Unit Curr.)2.240.132.06
Calculated EPS (Adj) (Unit Curr.)2.240.132.06
Calculated EPS (Ann.) (Unit Curr.)8.950.528.26
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.950.528.26
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.00735.000.00
Equity13.6213.6113.61
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)34.8027.5334.62
PBDTM(%)21.3713.5221.50
PATM(%)7.700.466.55